Michael Maszy - Endologix Vice President - Manufacturing

President

Mr. Michael P. Maszy is an Vice President Manufacturing of the Company. Mr. Maszy joined us in February 2016 following our merger with TriVascular. Mr. Maszy joined TriVascular in September 2010 and served in various roles of increasing responsibility with TriVascular, including as Vice President, Manufacturing prior to the merger. Mr. Maszy has over 16 years of experience in the medical device industry. Prior to joining TriVascular, Mr. Maszy served in various roles at Medtronic, Inc. from 2000 to 2010. Most recently, he led new product development teams at Medtronic Neurosurgery as Director of Project Management. Previously, Mr. Maszy led Operations for Medtronic Endovascular Innovations and also held positions in manufacturing engineering in Medtronic Peripheral Vascular and Ear, Nose and Throat divisions since 2016.
Age 40
Tenure 8 years
Professional MarksMBA
Phone949 595-7200
Webhttp://endologix.com
Maszy received an M.B.A. in Entrepreneurial Management from The Wharton School at The University of Pennsylvania and M.S. and B.S. degrees in Industrial and Systems Engineering from the University of Florida.

Endologix Management Efficiency

The company has return on total asset (ROA) of (9.82) % which means that it has lost $9.82 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (167.38) %, meaning that it created substantial loss on money invested by shareholders. Endologix's management efficiency ratios could be used to measure how well Endologix manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 195.94 M in liabilities with Debt to Equity (D/E) ratio of 3.67, implying the company greatly relies on financing operations through barrowing. Endologix has a current ratio of 0.38, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Endologix until it has trouble settling it off, either with new capital or with free cash flow. So, Endologix's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Endologix sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Endologix to invest in growth at high rates of return. When we think about Endologix's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Douglas BrinkworthSuburban Propane Partners
63
Jason WellsCenterPoint Energy
46
Scott DoyleCenterPoint Energy
52
Sue OrtenstoneCenterPoint Energy
62
Jason RyanCenterPoint Energy
48
Keith OnderdonkSuburban Propane Partners
55
Joseph McGoldrickCenterPoint Energy
62
Kristie ColvinCenterPoint Energy
56
Masatoshi SuzukiServiceNow
N/A
Alejandro BassoTransportadora de Gas
63
Kenneth MercadoCenterPoint Energy
57
William HoldenVistra Energy Corp
56
Lynne HarkelRumfordCenterPoint Energy
67
Tamesa RogersNETGEAR
50
Carrie KirbyVistra Energy Corp
56
Oscar SardiTransportadora de Gas
69
Nicolas MordegliaTransportadora de Gas
N/A
Kenneth ColemanCenterPoint Energy
N/A
Stephanie MooreVistra Energy Corp
51
Russell WrightCenterPoint Energy
40
Patrick CollinsNETGEAR
44
Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States and internationally. On July 5, 2020, Endologix, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Endologix operates under Medical Instruments Supplies classification in the United States and is traded on BATS Exchange. It employs 488 people. Endologix (ELGX) is traded on NASDAQ Exchange in USA and employs 488 people.

Management Performance

Endologix Leadership Team

Elected by the shareholders, the Endologix's board of directors comprises two types of representatives: Endologix inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Endologix. The board's role is to monitor Endologix's management team and ensure that shareholders' interests are well served. Endologix's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Endologix's outside directors are responsible for providing unbiased perspectives on the board's policies.
Christopher Chavez, Director
Greg Morrow, Chief Marketing Officer
John McDermott, Chairman of the Board, CEO
Patrick Stephens, Vice President - Research and Development
Leslie Norwalk, Director
Matthew Thompson, Chief Medical Officer
Gregory Waller, Independent Director
Jeffrey Stelk, Vice President - U.S. Sales
Guido Neels, Independent Director
Joseph DeJohn, Vice President - Sales
Michael Maszy, Vice President - Manufacturing
Shari OQuinn, Vice President - Regulatory and Quality Affairs
Charles Love, Vice President - Clinical Affairs
Janet Fauls, Director - Regulatory Affairs
John Onopchenko, COO
James Machek, Vice President - Research and Development
David Jennings, VP of HR
Vaseem Mahboob, CFO
Thomas Zenty, Independent Director
Amanda DePalma, VP of Global Marketing
Jose Lima, VP of Quality
Cecille Ferracci, General Manager - Europe
Jeff Fecho, Chief Quality Officer
Todd Abraham, Vice President - Operations
Michael Chobotov, CTO
Meredith Huetter, Vice President - Global Medical Affairs
Thomas Wilder, Independent Director
Daniel Lemaitre, Lead Independent Director
Robert Mitchell, President
Laura Nagel, Vice President - Global Quality
Jeremy Hayden, General Counsel, Corporate Secretary

Endologix Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Endologix a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Pair Trading with Endologix

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Endologix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Endologix will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Microsoft could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Microsoft when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Microsoft - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Microsoft to buy it.
The correlation of Microsoft is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Microsoft moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Microsoft moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Microsoft can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price.
Note that the Endologix information on this page should be used as a complementary analysis to other Endologix's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Consideration for investing in Endologix Stock

If you are still planning to invest in Endologix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Endologix's history and understand the potential risks before investing.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Global Correlations
Find global opportunities by holding instruments from different markets